Cited by 56Pancreatic function and diabetesIon channel regulation and functionCardiac electrophysiology and arrhythmias

Enhanced Glucose Tolerance by SK4 Channel Inhibition in Pancreatic β-Cells

Open access
Düfer, Martina, Gier, Belinda, Wolpers, Daniela, Krippeit-Drews, Peter, Ruth, Peter, Drews, Gisela·2009·Diabetes

Abstract

OBJECTIVE: Ca2+-regulated K+ channels are involved in numerous Ca2+-dependent signaling pathways. In this study, we investigated whether the Ca2+-activated K+ channel of intermediate conductance SK4 (KCa3.1, IK1) plays a physiological role in pancreatic β-cell function. RESEARCH DESIGN AND METHODS: Glucose tolerance and insulin sensitivity were determined in wild-type (WT) or SK4 knockout (SK4-KO) mice. Electrophysiological experiments were performed with the patch-clamp technique. The cytosolic Ca2+ concentration ([Ca2+]c) was determined by fura-2 fluorescence. Insulin release was assessed by radioimmunoassay, and SK4 protein was detected by Western blot analysis. RESULTS: SK4-KO mice showed improved glucose tolerance, whereas insulin sensitivity was not altered. The animals were not hypoglycemic. Isolated SK4-KO β-cells stimulated with 15 mmol/l glucose had an increased Ca2+ action potential frequency, and single-action potentials were broadened. These alterations were coupled to increased [Ca2+]c. In addition, glucose responsiveness of membrane potential, [Ca2+]c, and insulin secretion were shifted to lower glucose concentrations. SK4 protein was expressed in WT islets. An increase in K+ currents and concomitant membrane hyperpolarization could be evoked in WT β-cells by the SK4 channel opener DCEBIO (100 μmol/l). Accordingly, the SK4 channel blocker TRAM-34 (1 μmol/l) partly inhibited KCa currents and induced electrical activity at a threshold glucose concentration. In stimulated WT β-cells, TRAM-34 further increased [Ca2+]c and broadened action potentials similar to those seen in SK4-KO β-cells. SK4 channels were found to substantially contribute to Kslow (slowly activating K+ current). CONCLUSIONS: SK4 channels are involved in β-cell stimulus-secretion coupling. Deficiency of SK4 current induces elevated β-cell responsiveness and coincides with improved glucose tolerance in vivo. Therefore, pharmacologic modulation of these channels might provide an interesting approach for the development of novel insulinotropic drugs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db08-1324

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • β-cells from Kcnn4-deficient mice exhibit increased excitability, enhanced GIIS and improved glucose tolerance in vivo.

    “Although SK4 channels (Kcnn4) are expressed at low levels (only 5% of Kccn3), β-cells from Kcnn4-deficient mice exhibit increased excitability, enhanced GIIS and improved glucose tolerance in vivo (156).”
  • The single-channel conductance of Kslow recorded with symmetrical 130 mM K+ solutions is 39 pS.

    “The single-channel conductance recorded with symmetrical 130 mM K+ solutions is 39 pS (156).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 53

  1. [1]Hoffman JF Joiner W Nehrke K Potapova O Foye K Wickrema A: The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells. Proc Natl Acad Sci U S A 2003; 100: 7366– 7371 12773623 PMC165881
  2. [2]Jensen BS Strobaek D Christophersen P Jorgensen TD Hansen C Silahtaroglu A Olesen SP Ahring PK: Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol 1998; 275: C848– C856 9730970
  3. [3]Begenisich T Nakamoto T Ovitt CE Nehrke K Brugnara C Alper SL Melvin JE: Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem 2004; 279: 47681– 47687 15347667
  4. [4]Matos JE Sausbier M Beranek G Sausbier U Ruth P Leipziger J: Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl-secretion. Acta Physiol 2007; 189: 251– 258 17305705
  5. [5]Shumilina E Lam RS Wölbing F Matzner N Zemtsova IM Sobiesiak M Mahmud H Sausbier U Biedermann T Ruth P Sausbier M Lang F: Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1. J Immunol 2008; 180: 8040– 8047 18523267
  6. [6]Chang MC Khanna R Schlichter LC: Regulation of Kv1.3 channels in activated human T lymphocytes by Ca2+-dependent pathways. Cell Physiol Biochem 2001; 11: 123– 134 11410708
  7. [7]Deng XL Lau CP Lai K Cheung KF Lau GK Li GR: Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow. Cell Prolif 2007; 40: 656– 670 17877608 PMC6496559
  8. [8]Nguyen TV Matsuyama H Baell J Hunne B Fowler CJ Smith JE Nurgali K Furness JB: Effects of compounds that influence IK (KCNN4) channels on afterhyperpolarizing potentials, and determination of IK channel sequence, in guinea pig enteric neurons. J Neurophysiol 2007; 97: 2024– 2031 17229825
  9. [9]Ishii TM Silvia C Hirschberg B Bond CT Adelman JP Maylie J: A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 1997; 94: 11651– 11656 9326665 PMC23567
  10. [10]Tamarina NA Wang Y Mariotto L Kuznetsov A Bond C Adelman J Philipson LH: Small-conductance calcium-activated K+ channels are expressed in pancreatic islets and regulate glucose responses. Diabetes 2003; 52: 2000– 2006 12882916
  11. [11]Seghers V Nakazaki M DeMayo F Aguilar-Bryan L Bryan J: Sur1 knockout mice: a model for KATP channel-independent regulation of insulin secretion. J Biol Chem 2000; 275: 9270– 9277 10734066
  12. [12]Shiota C Larsson O Shelton KD Shiota M Efanov AM Hoy M Lindner J Kooptiwut S Juntti-Berggren L Gromada J Berggren PO Magnuson MA: Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 2002; 277: 37176– 37183 12149271
  13. [13]Miki T Nagashima K Tashiro F Kotake K Yoshitomi H Tamamoto A Gonoi T Iwanaga T Miyazaki J Seino S: Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci U S A 1998; 95: 10402– 10406 9724715 PMC27906
  14. [14]Düfer M Haspel D Krippeit-Drews P Aguilar-Bryan L Bryan J Drews G: Oscillations of membrane potential and cytosolic Ca2+ concentration in SUR1-/- beta cells. Diabetologia 2004; 47: 488– 498 14872319
  15. [15]Eliasson L Ma X Renström E Barg S Berggren PO Galvanovskis J Gromada J Jing X Lundquist I Salehi A Sewing S Rorsman P: SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells. J Gen Physiol 2003; 121: 181– 197 12601083 PMC2217330
  16. [16]Haspel D Krippeit-Drews P Aguilar-Bryan L Bryan J Drews G Düfer M: Crosstalk between membrane potential and cytosolic Ca2+ concentration in beta cells from Sur1-/- mice. Diabetologia 2005; 48: 913– 921 15830184
  17. [17]Szollosi A Nenquin M Henquin JC: Overnight culture unmasks glucose-induced insulin secretion in mouse islets lacking ATP-sensitive K+ channels by improving the triggering Ca2+ signal. J Biol Chem 2007; 282: 14768– 14776 17389589
  18. [18]Ferrer J Wasson J Salkoff L Permutt MA: Cloning of human pancreatic islet large conductance Ca2+-activated K+ channel (hSlo) cDNAs: evidence for high levels of expression in pancreatic islets and identification of a flanking genetic marker. Diabetologia 1996; 39: 891– 898 8858210
  19. [19]Yan L Figueroa DJ Austin CP Liu Y Bugianesi RM Slaughter RS Kaczorowski GJ Kohler MG: Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. Diabetes 2004; 53: 597– 607 14988243
  20. [20]Smith PA Bokvist K Arkhammar P Berggren PO Rorsman P: Delayed rectifying and calcium-activated K+ channels and their significance for action potential repolarization in mouse pancreatic beta-cells. J Gen Physiol 1990; 95: 1041– 1059 2197368 PMC2216351
  21. [21]MacDonald PE Wheeler MB: Voltage-dependent K+ channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia 2003; 46: 1046– 1062 12830383
  22. [22]Jacobson DA Philipson LH: Action potentials and insulin secretion: new insights into the role of Kv channels. Diabetes Obes Metab 2007; 2 (Suppl. 9): 89– 98 17919183 PMC5878925
  23. [23]Roe MW Worley JF 3rd Mittal AA Kuznetsov A DasGupta S Mertz RJ Witherspoon SM 3rd Blair N Lancaster ME McIntyre MS Shehee WR Dukes ID Philipson LH: Expression and function of pancreatic beta-cell delayed rectifier K+ channels: role in stimulus-secretion coupling. J Biol Chem 1996; 271: 32241– 32246 8943282
  24. [24]Su J Yu H Lenka N Hescheler J Ullrich S: The expression and regulation of depolarization-activated K+ channels in the insulin-secreting cell line INS-1. Pflügers Arch 2001; 442: 49– 56 11374068
  25. [25]MacDonald PE Sewing S Wang J Joseph JW Smukler SR Sakellaropoulos G Wang J Saleh MC Chan CB Tsushima RG Salapatek AM Wheeler MB: Inhibition of Kv2.1 voltage-dependent K+ channels in pancreatic beta-cells enhances glucose-dependent insulin secretion. J Biol Chem 2002; 277: 44938– 44945 12270920
  26. [26]Jacobson DA Kuznetsov A Lopez JP Kash S Ämmälä CE Philipson LH: Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion. Cell Metab 2007; 6: 229– 235 17767909 PMC2699758
  27. [27]Ribalet B Beigelman PM: Calcium action potentials and potassium permeability activation in pancreatic beta-cells. Am J Physiol 1980; 239: C124– C133 7001912
  28. [28]Ämmälä C Larsson O Berggren PO Bokvist K Juntti-Berggren L Kindmark H Rorsman P: Inositol trisphosphate-dependent periodic activation of a Ca2+-activated K+ conductance in glucose-stimulated pancreatic beta-cells. Nature 1991; 353: 849– 852 1719424
  29. [29]Ribalet B Eddlestone GT Ciani S: Metabolic regulation of the KATP and a maxi-KV channel in the insulin-secreting RINm5F cell. J Gen Physiol 1988; 92: 219– 237 3049931 PMC2228897
  30. [30]Satin LS Hopkins WF Fatherazi S Cook DL: Expression of a rapid, low-voltage threshold K current in insulin-secreting cells is dependent on intracellular calcium buffering. J Membr Biol 1989; 112: 213– 222 2515282
  31. [31]Kukuljan M Goncalves AA Atwater I: Charybdotoxin-sensitive KCa channel is not involved in glucose-induced electrical activity in pancreatic beta-cells. J Membr Biol 1991; 119: 187– 195 1710672
  32. [32]Henquin JC: Role of voltage- and Ca2+-dependent K+ channels in the control of glucose-induced electrical activity in pancreatic B-cells. Pflügers Arch 1990; 416: 568– 572 2235297
  33. [34]Kanno T Rorsman P Göpel SO: Glucose-dependent regulation of rhythmic action potential firing in pancreatic beta-cells by KATP-channel modulation. J Physiol 2002; 545: 501– 507 12456829 PMC2290696
  34. [35]Zhang M Houamed K Kupershmidt S Roden D Satin LS: Pharmacological properties and functional role of Kslow current in mouse pancreatic beta-cells: SK channels contribute to Kslow tail current and modulate insulin secretion. J Gen Physiol 2005; 126: 353– 363 16186562 PMC2266621
  35. [36]Grynkiewicz G Poenie M Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440– 3450 3838314
  36. [38]Wulff H Miller MJ Hansel W Grissmer S Cahalan MD Chandy KG: Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 2000; 97: 8151– 8156 10884437 PMC16685
  37. [40]Singh S Syme CA Singh AK Devor DC Bridges RJ: Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 2001; 296: 600– 611 11160649
  38. [41]Hamilton KL Kiessling M: DCEBIO stimulates Cl− secretion in the mouse jejunum. Am J Physiol Cell Physiol 2006; 290: C152– C164 16135545
  39. [42]Morimura K Yamamura H Ohya S Imaizumi Y: Voltage-dependent Ca2+-channel block by openers of intermediate and small conductance Ca2+-activated K+ channels in urinary bladder smooth muscle cells. J Pharmacol Sci 2006; 100: 237– 241 16518073
  40. [43]Hirukawa K Muraki K Ohya S Imaizumi Y Togari A: Electrophysiological properties of a novel Ca2+-activated K+ channel expressed in human osteoblasts. Calcif Tissue Int 2008; 83: 222– 229 18787886
  41. [44]Ohya S Kimura S Kitsukawa M Muraki K Watanabe M Imaizumi Y: SK4 encodes intermediate conductance Ca2+-activated K+ channels in mouse urinary bladder smooth muscle cells. Jpn J Pharmacol 2000; 84: 97– 100 11043463
  42. [45]Wei AD Gutman GA Aldrich R Chandy KG Grissmer S Wulff H: International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 2005; 57: 463– 472 16382103
  43. [46]Ashcroft FM Rorsman P: Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 1989; 54: 87– 143 2484976
  44. [47]Zhou Z Misler S: Amperometric detection of quantal secretion from patch-clamped rat pancreatic beta-cells. J Biol Chem 1996; 271: 270– 277 8550572
  45. [48]Kozak JA Misler S Logothetis DE: Characterization of a Ca2+-activated K+ current in insulin-secreting murine betaTC-3 cells. J Physiol 1998; 509: 355– 370 9575286 PMC2230977
  46. [49]Meissner HP Schmelz H: Membrane potential of beta-cells in pancreatic islets. Pflügers Arch 1974; 351: 195– 206 4608967
  47. [51]Smith PA Ashcroft FM Rorsman P: Simultaneous recordings of glucose dependent electrical activity and ATP-regulated K+-currents in isolated mouse pancreatic beta-cells. FEBS Lett 1990; 261: 187– 190 2407553
  48. [52]Vogalis F Zhang Y Goyal RK: An intermediate conductance K+ channel in the cell membrane of mouse intestinal smooth muscle. Biochim Biophys Acta 1998; 1371: 309– 316 9630695
  49. [53]Ledoux J Werner ME Brayden JE Nelson MT: Calcium-activated potassium channels and the regulation of vascular tone. Physiology 2006; 21: 69– 78 16443824
  50. [54]Larsson-Nyrén G Sehlin J Rorsman P Renström E: Perchlorate stimulates insulin secretion by shifting the gating of L-type Ca2+ currents in mouse pancreatic B-cells towards negative potentials. Pflügers Arch 2001; 441: 587– 595 11294239
  51. [55]Nelson MT Patlak JB Worley JF Standen NB: Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 1990; 259: C3– C18 2164782
  52. [56]Si H Heyken WT Wölfle SE Tysiac M Schubert R Grgic I Vilianovich L Giebing G Maier T Gross V Bader M de Wit C Hoyer J Köhler R: Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006; 99: 537– 544 16873714
  53. [58]Schernthaner G Grimaldi A Di Mario U Drzewoski J Kempler P Kvapil M Novials A Rottiers R Rutten GE Shaw KM: GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 2004; 34: 535– 542 15305887

Cited by

Sorted by citations

Authors
Düfer, M., Gier, B., Wolpers, D., Krippeit-Drews, P., Ruth, P., & Drews, G.
Affiliations
  • University of Tübingen (DE)
  • From the Institute of Pharmacy, the Department of Pharmacology, University of Tübingen, Tübingen, Germany.
Corresponding author
Drews, Gisela
Venue
Diabetes
Published
2009-04-28
Volume
58
Issue
8
Pages
1835-1843
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2116424238
Cited by
56
References
4
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 5 · 2015: 6 · 2014: 6 · 2012: 6
FWCI
6.08
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
KCa3.1, intermediate-conductance calcium-activated potassium channel, pancreatic beta cells, glucose tolerance, insulin secretion, stimulus-secretion coupling, intracellular calcium, membrane potential, TRAM-34, insulin sensitivity
MeSH terms
Animals, Blood Glucose, Crosses, Genetic, Female, Glucose Tolerance Test, Male, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Knockout, Insulin-Secreting Cells, Mice, Intermediate-Conductance Calcium-Activated Potassium Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review